Targets & Medicines in the Age of the CRISPR
Come to the inaugural LGR Symposium and learn how this lab aims to facilitate and accelerate collaborations between GSK and UC scientists and clinicians.
Register Here
Digital Health Wins Big at UCSF Awards Event
Anne Wojcicki (23 and Me), Glen Tullman (Livongo), and Sean Duffy (Omada Health) inaugurate the UCSF Digital Health Innovation Hall of Fame.
Read More
From the Lab to the Bedside
Join UCSF’s Entrepreneurs in Residence (EIRs) and provide valuable expertise to UCSF’s most promising ideas. More Information to come.
InVest In Ourselves...
The UCSF InVent Fund is open for business! Innovation Ventures supports faculty whose inventions would benefit from licensing to new or established companies with the expertise and funding to develop those further.
Apply Here
UC Announces Collaboration in Data Science Research
New fellowship program facilitated by Johnson & Johnson with UCSF and UC Berkeley to recruit data scientists for data-driven healthcare research.
Read More
UC’s CRISPR Expertise to Speed Drug Discovery
Jennifer Doudna and Jonathan Weissman are the key players in a new collaboration with GlaxoSmithKline to apply CRISPR techniques to the discovery of new drug targets, potentially leading to new therapies for genetic diseases.
Read More
Exploring a Patient-First Partnership
Scientists at AbbVie and University of California, San Francisco collaborate with patient needs in mind.
Read More
Tumor Regression Discovery Gets Green
Once considered an un-druggable target, a novel, small molecule approach to induce tumor regression was discovered by UCSF's Kevan Shokat, Ph.D. Now the FDA has cleared the IND application for clinical development.
Read More
Tmunity and UCSF Announce Collaboration
Tmunity agrees to exclusive license and research collaboration with UCSF's Hideho Okada, a physician-scientist and professor of neurological surgery who studies immunotherapeutic strategies aimed at malignant brain tumors.
Read Article
Scientists Create Speech From Brain Signals
A prosthetic voice decodes what the brain intends to say and generates (mostly) understandable speech, no muscle movement needed.
Read More
The Mysterious Hormone Called Klotho
Dr. Dena Dubal worked to understand how to enhance the brain's capabilities. Now she is trying to build treatments based on these results.
Read More

Who We Are

Translational technology development and commercialization is a complex process because every project is unique. Innovation Ventures is dedicated to helping the UCSF community navigate those complexities by working up-close with our research faculty and promising students to really understand their science. We have a single purpose and that is to support the transition of UCSF innovation out of the lab and into the marketplace as more fully developed therapies, with a greater confidence of success. Whether evaluating a new discovery, securing funding, seeking external partnerships, or starting new companies, Innovation Ventures is here to facilitate protection, development, and commercialization of novel and valuable healing inventions.

From Innovation...

...to Impact